Eu Ivdd
Eu Ivd General
On The Market
🇺🇸 United States
ACCURUN 130 Borrelia burgdorferi IgG Positive Control
Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0
Basic Information
- Primary DI
- 00816784020376
- Basic UDI-DI Code
- B-00816784020376
- Reference
- 2015-0080
- Device Types
- None provided
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- LGC Clinical Diagnostics, Inc.
Additional Description
ACCURUN® 130 Borrelia burgdorferi IgG Positive Control is formulated for use as an unassayed serum control with in vitro diagnostic test kits for the qualitative detection of IgG antibodies to Borrelia burgdorferi (Lyme Disease).
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0105080801 | BACTERIOLOGY CONTROLS - INF.IMM. |
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).
BluBox
Device
EU IVDD
·
Eu Ivd General
·Blusense Diagnostics ApS·On the market·5 countries
extendSURE™ HbA1c Liquid Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·19 countries
ViroTrack Sero COVID-19 Total Ab
Device
EU IVDD
·
Eu Ivd General
·Blusense Diagnostics ApS·On the market·5 countries
extendSURETM Haemoglobin F and A2 Calibrators
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·8 countries
extendSURE™ Haemoglobin F and A2 Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·8 countries
extendSURE™ HbA1c Liquid Controls
Device
EU IVDD
·
Eu Ivd General
·Canterbury Scientific Limited·On the market·19 countries